ZA986877B - Pharmaceutical formulation for camptothecin analogues in gelatin capsule - Google Patents

Pharmaceutical formulation for camptothecin analogues in gelatin capsule

Info

Publication number
ZA986877B
ZA986877B ZA986877A ZA986877A ZA986877B ZA 986877 B ZA986877 B ZA 986877B ZA 986877 A ZA986877 A ZA 986877A ZA 986877 A ZA986877 A ZA 986877A ZA 986877 B ZA986877 B ZA 986877B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
gelatin capsule
camptothecin analogues
camptothecin
analogues
Prior art date
Application number
ZA986877A
Inventor
Kamlesh Patel
Tomasz Herzyk
Nageswara R Palepu
Gregory Allen Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA986877B publication Critical patent/ZA986877B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA986877A 1997-08-01 1998-07-31 Pharmaceutical formulation for camptothecin analogues in gelatin capsule ZA986877B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90476197A 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
ZA986877B true ZA986877B (en) 1999-06-15

Family

ID=25419727

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986877A ZA986877B (en) 1997-08-01 1998-07-31 Pharmaceutical formulation for camptothecin analogues in gelatin capsule

Country Status (5)

Country Link
AR (1) AR013261A1 (en)
AU (1) AU8604598A (en)
CO (1) CO4970695A1 (en)
WO (1) WO1999006031A1 (en)
ZA (1) ZA986877B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281223B1 (en) * 1999-04-13 2001-08-28 Supergen, Inc. Radioenhanced camptothecin derivative cancer treatments
GB9918885D0 (en) * 1999-08-10 1999-10-13 Pharmacia & Upjohn Spa Pharmaceutical formulations in hydroxypropymethycellulose capsules
AU2005222541B2 (en) * 1999-08-10 2008-07-24 Pharmacia & Upjohn S.P.A. Pharmaceutical formulations in hydroxypropylmethylcellulose capsules
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
AR046579A1 (en) * 2003-11-12 2005-12-14 Smithkline Beecham Corp TOPOTECAN CRYSTAL COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE TO PREPARE IT AND ITS USE TO PREPARE SUCH PHARMACEUTICAL COMPOSITION
GT200500310A (en) 2004-11-19 2006-06-19 ORGANIC COMPOUNDS
SA06270147B1 (en) 2005-06-09 2009-12-22 نوفارتيس ايه جي Process for the Synthesis Of 5-(methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine
ITRM20050418A1 (en) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti IMMEDIATE RELEASE THERAPEUTIC SYSTEMS FOR THE IMPROVED ORAL ABSORPTION OF 7 - [(E) -T-BUTYLOSSIMINOMETHYL] CAMPTOTECIN.
US9320690B2 (en) * 2010-12-20 2016-04-26 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
MY163496A (en) * 2010-12-20 2017-09-15 Colgate Palmolive Co Non-aqueous oral care composition containing dental occlusion actives
EP2654672B1 (en) 2010-12-20 2017-03-08 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5225404A (en) * 1989-11-06 1993-07-06 New York University Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
US5468754A (en) * 1994-04-19 1995-11-21 Bionumerik Pharmaceuticals, Inc. 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
US5677286A (en) * 1995-04-27 1997-10-14 The University Of Michigan Glycosylated analogs of camptothecin

Also Published As

Publication number Publication date
AU8604598A (en) 1999-02-22
CO4970695A1 (en) 2000-11-07
WO1999006031A1 (en) 1999-02-11
AR013261A1 (en) 2000-12-13

Similar Documents

Publication Publication Date Title
HUP0004534A3 (en) Pharmaceutical formulation containing olanzapine
ZA982872B (en) Pharmaceutical formulation
HUP0100179A3 (en) Imidazopyrimidine and imidazopyridine derivatives and pharmaceutical compositions thereof
EG24044A (en) pharmaceutical formulation of omeprazole
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
HUP0002209A3 (en) 4-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical compositions containing them
ZA989740B (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
IL143580A0 (en) Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof
GB9713149D0 (en) Pharmaceutical formulations
HUP0002510A3 (en) Tetrazole derivatives and pharmaceutical compositions containing them
HUP0002324A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
HU9800147D0 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
ZA986877B (en) Pharmaceutical formulation for camptothecin analogues in gelatin capsule
EP1013269A4 (en) Improvement in medicament administration system
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
GB9918885D0 (en) Pharmaceutical formulations in hydroxypropymethycellulose capsules
IL134538A (en) Lactacystin derivatives and pharmaceutical compositions containing the same
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
ZA982073B (en) Pharmaceutical preparation
IL132986A0 (en) Rapamycin formulation for oral administration
GB9709739D0 (en) Pharmaceutical formulation
HUP0001010A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
ZA981775B (en) Pharmaceutical formulations containing poorly soluble drug substances
HUP0200812A3 (en) Vitamin d analogues and their pharmaceutical use